Clinical trial
Identification of Biomarkers Associated With Disease Worsening Within 10 Years in Scleroderma Patients
NCT04986514 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of Biomarkers Associated With Disease Worsening Within 10 Years in Scleroderma Patients
- Lead sponsor
- University Hospital, Lille
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- April 30, 2023
- Completion date
- April 30, 2043
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
systemic sclerosis